Are Aspects of Integrative Concepts Helpful to Improve Pancreatic Cancer Therapy?
Shiao Li OeiFriedemann SchadPublished in: Cancers (2023)
Numerous clinical studies have been conducted to improve the outcomes of patients suffering from pancreatic cancer. Different approaches using targeted therapeutic strategies and precision medicine methods have been investigated, and synergies and further therapeutic advances may be achieved through combinations with integrative methods. For pancreatic tumors, a particular challenge is the presence of a microenvironment and a dense stroma, which is both a physical barrier to drug penetration and a complex entity being controlled by the immune system. Therefore, the state of immunological tolerance in the tumor microenvironment must be overcome, which is a considerable challenge. Integrative approaches, such as hyperthermia, percutaneous irreversible electroporation, intra-tumoral injections, phytotherapeutics, or vitamins, in combination with standard-oncological therapies, may potentially contribute to the control of pancreatic cancer. The combined application of standard-oncological and integrative methods is currently being studied in ongoing clinical trials. An actual overview is given here.
Keyphrases
- cancer therapy
- clinical trial
- end stage renal disease
- network analysis
- newly diagnosed
- ejection fraction
- rectal cancer
- chronic kidney disease
- drug delivery
- radical prostatectomy
- ultrasound guided
- physical activity
- prognostic factors
- mental health
- prostate cancer
- peritoneal dialysis
- emergency department
- randomized controlled trial
- patient reported outcomes
- high resolution
- skeletal muscle
- drug induced
- weight loss
- insulin resistance
- study protocol
- phase ii
- double blind